Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database

INTRODUCTION: Diabetes is a growing epidemic that imposes a substantial economic burden on healthcare systems. This study aimed to evaluate the cost of managing type 2 diabetes (T2D) with dipeptidyl peptidase 4 inhibitors (DPP4Is) using real-world data. METHOD: This longitudinal study used data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Corinne, Torreton, Elodie, Dejager, Sylvie, Levy-Bachelot, Laurie, Bineau, Sébastien, Detournay, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995803/
https://www.ncbi.nlm.nih.gov/pubmed/31953694
http://dx.doi.org/10.1007/s13300-020-00760-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995803/
https://www.ncbi.nlm.nih.gov/pubmed/31953694
http://dx.doi.org/10.1007/s13300-020-00760-x

Ejemplares similares